The Recall Desk
CriticalFDA (Drugs)·D-0337-2018·Announced 2018-02-14

AuroMedics Recalls Linezolid Injection Bags Due to Mold Contamination

AuroMedics Pharma LLC is recalling 9,050 bags of Linezolid Injection 600 mg/300 mL because white particulate matter identified as mold was found in one bag.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

AuroMedics Pharma LLC is recalling 9,050 bags of Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags. The product is identified by Lot # CLZ160007 and has an expiration date of August 2018. The NDC for the product is 55150-242-51.

The recall was initiated because white particulate matter, identified as mold, was found in one bag. The product was distributed throughout the United States.

Healthcare providers and patients should stop using the affected product and contact AuroMedics Pharma LLC for further instructions or a replacement.

The recalled product

Product
LINEZOLID (LINEZOLID)
Brand
LINEZOLID
Affected units
9,050

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # CLZ160007
  • Exp August 2018

Distribution

Distribution scope not specified by the agency.

Same brand · LINEZOLID